Helus Pharma announced the appointment of Dr. Ken Kramer, PhD as Senior Vice President, Medical Affairs, effective April 16, 2026. Dr. Kramer joins Helus with more than two decades of experience leading medical affairs strategy across neuroscience programs, including global launch readiness, evidence generation, and engagement with key opinion leaders. Most recently, he served as Vice President and Head of Medical Neuroscience at Bristol Myers Squibb, where he led an integrated medical strategy team to successfully launch the first new treatment for schizophrenia in over seven decades.
At Karuna Therapeutics, as VP and Head of Medical Affairs, Dr. Kramer built and expanded medical capabilities during a period of significant organizational growth and supported the organization through its acquisition. Earlier in his career, Dr. Kramer spent more than a decade leading U.S. psychiatry medical affairs teams at AbbVie and its predecessor organizations, contributing to multiple successful product launches. He began his career in academic medicine as an Assistant Professor of Psychiatry.
Dr. Kramer holds a Ph.D. in Neuropharmacology from New York University and an M.S. in Neuroscience and a B.S. in Biology from the University of Rochester.
